References
- Murad F. Introduction and some historical comments. In: August JT, Anders MW, Murad F, editors. Advances in pharmacology. Cyclic GMP: Synthesis, metabolism, and function. vol. 26. San Diego: Academic Press; 1994. p 1–5.
- Cooke JP, Taso PS. Atherosclerosis: Role of NO. In: Rubanyi GM, editor. Pathophysiological and clinical applications of nitric oxide. Part B. Australia: Harwood Academic Publishers; 1999. p 283–297.
- Jubelin BC, Gierman JL. Erythrocytes may synthesize their own nitric oxide. Am J Hypertens 1996;9:1214–1219.
- Chen LY, Mehta JL. Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: Relevance in the effects of red blood cells on platelet function. J Cardiovasc Pharmacol 1998;32:57–64.
- Kang ES, Ford K, Grokulsky G, Wang YB, Chiang TM, Acchiardo SR. Normal circulating adult human red blood cells contain inactive NOS proteins. J Lab Chin Med 2000;135: 444–451.
- Durak I, Cimen MY, Cimen OB, Kacmaz M, Goren D, Ozturk HS. Aspirin induces erythrocyte nitric oxide synthase activity in vivo. Chin Chim Acta 2001;314:265–267.
- Pacelli R, Taira J, Cook JA, Wink DA, Krishna MC. Hydroxyurea reacts with heme proteins to generate nitric oxide. Lancet 1996;347:900.
- King SB. N-Hydroxyurea and acyl nitroso compounds as nitroxyl (HNO) and nitric oxide (NO) donors. Curr Top Med Chem 2005;5:665–673.
- King SB. Nitric oxide production from hydroxyurea. Free Radic Biol Med 2004;37:737–744.
- Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317–1322.
- Ponka P. Cell biology of heme. Am J Med Sci 1999;318: 241–256.
- Gowda DC, Davidson EA. Protein glycosylation in the malaria parasite. Parasitol Today 1999;15:147–152.
- Rodriguez GI, Kuhn JG, Weiss GR, et al. A bioavailability and pharmacokinetic study of oral and intravenous hydroxyurea. Blood 1998;91:1533–1541.
- Braman RS, Hendrix SA. Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection. Anal Chem 1989;61:2715–2718.
- Nahavandi M, Wyche MQ, Perlin E, Castro O, Tavakkoli F. Nitric oxide metabolites in sickle cell anemia patients after oral administration of hydroxyurea. Hematology 2000;5:335–339.
- Nahavandi M, Wyche MQ, Perlin E, Castro O, Tavakkoli F. Nitric oxide metabolites and cGMP levels in sickle cell anemia patients receiving hydroxyurea. Br J Haematol 2002;119: 855–857.
- Jensen FB. Nitrite transport into pig erythrocytes and potential biological role. Acta Physiol Scand 2005;184:243–251.
- Iyamu EW, Cecil R, Parkin L, Woods G, Ohene-Frempong K, Asakura T. Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy. Br J Haematol 2005;131:389–394.